WILLIAMS KRISTEN 4
4 · Pacira BioSciences, Inc. · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
Pacira (PCRX) Chief Admin Officer Kristen Williams Receives Award
What Happened
- Kristen Williams, Chief Administrative Officer of Pacira BioSciences (PCRX), was granted 54,546 restricted stock units (RSUs) on 2026-02-11. The grant is shown at $0.00 per unit (an award/compensation grant), so no cash purchase or sale occurred.
- The filing lists the transaction date as Feb 11, 2026 and was reported on Form 4 filed Feb 13, 2026.
Key Details
- Transaction type: Award/Grant (code A)
- Date of grant: 2026-02-11; Form 4 filed: 2026-02-13 (appears timely under the 2-business-day rule)
- Amount: 54,546 restricted stock units; price reported: $0.00 (no cash exchanged)
- Vesting: RSUs vest in four equal annual installments beginning Feb 15, 2027, contingent on continuous service (each RSU converts to one common share on vesting)
- Shares owned after transaction: not specified in the information provided
- No 10b5-1, tax-withholding sale, or immediate sale noted in this filing
Context
- These RSUs are a compensation award, not an open-market purchase or sale; they generally don’t convey voting rights or settled shares until each tranche vests and is delivered.
- Awards like this are common for executive compensation and reflect grant-based remuneration rather than an insider trading signal.
Insider Transaction Report
Form 4
WILLIAMS KRISTEN
Chief Administrative Officer
Transactions
- Award
Common Stock
[F1]2026-02-11+54,546→ 185,849 total
Footnotes (1)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
Signature
/s/ Kristen Williams|2026-02-13